Get the insider’s perspective from our one-of-a-kind team with diverse skills and integrated expertise.
Let our interdisciplinary proccess work for you!

We created internal training materials for FDA Medical Officers and Pre-Market Reviewers that are still used to this day. We also secured the first-ever FDA Breakthrough Device Designations for treating Alzheimer’s disease.

Our team is comprised of former FDA senior officials, industry veterans, and academic stakeholders with 250+ years of combined insight.

We helped dozens companies secure marketing authorizations, supporting both premarket submissions and postmarket compliance.
Integrated regulatory and clinical strategy - defining the FDA pathway, evidence strategy, and development roadmap.
A decision-grade regulatory assessment for existing and potential investments.
Review-ready submissions that support efficient FDA review.
Mock audits, gap assessments, and remediation planning.
A decisive assessment and reset plan when programs stall.
High-stakes FDA engagements demand precision.

Assessment of least-burdensom
pathway(s), evidence, requirements, and operational feasibility.

Risk-based strategy developed to align with your goals and needs.

FDA-ready deliverables with hands-on support for your team.

Targeted FDA engagement and iterative refinement based on Agency feedback.
Stop guessing what the reviewer wants. Ask someone who used to be one.
Together, our strong, experienced team brings integrated expertise across clinical, regulatory, and market access domains to identify the fastest paths to FDA and market success.
Let our interdisciplinary proccess work for you!
Schedule a consultation today!
Copyright © 2026 FDA Partners - All Rights Reserved.
Reach Us at: (732) 754-2073